Your science-driven CDMO dedicated to Cell Therapy

Cell Easy is a rapidly growing Contract Development and Manufacturing Services organization (CDMO) with a dedicated focus on Advanced Cell Therapies.

Established in 2017, Cell Easy's commitment extends beyond development and manufacturing; it also places a strong emphasis on regulatory and analytical aspects. Cell Easy offers a comprehensive suite of services, including process development, process scale-up, cGMP manufacturing, and analytical support for immune cells (engineered CAR-T, NK cells, and non-engineered cells) as well as adult stem cells (MSCs, iPSCs, and Exosomes).

Our company has achieved significant milestones, such as advancing programs to Phase 2, partnering with top 30 international pharmaceutical companies, transitioning from autologous to allogenic processes.

With tailored CDMO solutions, Cell Easy is dedicated to efficiently bridging the gap between R&D projects and clinical development, saving both time and costs. Explore our full range of services at www.cell-easy.com